Sequence-based identification and characterization of nosocomial influenza A(H1N1)pdm09 virus infections

2012 ◽  
Vol 82 (3) ◽  
pp. 187-193 ◽  
Author(s):  
M. Jonges ◽  
J. Rahamat-Langendoen ◽  
A. Meijer ◽  
H.G. Niesters ◽  
M. Koopmans
2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Sarah Spencer ◽  
Ha Nguyen ◽  
Anwar Abd Elal ◽  
Angela P. Campbell ◽  
Jennifer Laplante ◽  
...  

Author(s):  
Marianne Wedde ◽  
Djin-Ye Oh ◽  
Silke Buda ◽  
Andrea Thürmer ◽  
Sandra Kaiser ◽  
...  

Background Influenza A(H1N1)pdm09 virus entered the human population in 2009 and evolved within this population for more than ten years. Despite genetic evolution no remarkable changes in the antigenic reactive pattern of these viruses were observed so far. Methods Primary respiratory samples of the German influenza virological sentinel were investigated by qPCR. Influenza virus-positive samples were characterized genetically and antigenetically. Results In December 2019, a antigenic drift variant characterized by an N156K substitution in the hemagglutinin of influenza A(H1N1)pdm09 virus emerged in Germany, which exhibited a reactivity to ferret antiserum that was an average 6 log2 lower than the vaccine virus A/Brisbane/02/2018 and the other A(H1N1)pdm09 viruses circulating in the influenza season 2019-2020. These viruses accounted for 20% of all A(H1N1)pdm09 viruses characterized in the German influenza sentinel. Patients infected with these viruses had a shorter median time period of medical consultation after onset of symptoms and were more frequently treated with neuraminidase inhibitors in comparison to patients infected with other A(H1N1)pdm09 viruses. Conclusions This parallel circulation of two antigenic variants of A(H1N1)pdm09 viruses which differ remarkably in their antigenic reactive pattern contributes to a greater variability in circulating influenza viruses and challenges vaccination.


PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e50116 ◽  
Author(s):  
Daniela de la Rosa-Zamboni ◽  
Joel A. Vázquez-Pérez ◽  
Santiago Ávila-Ríos ◽  
Ana Paola Carranco-Arenas ◽  
Christopher E. Ormsby ◽  
...  

2019 ◽  
Vol 8 (1) ◽  
pp. 404-412 ◽  
Author(s):  
Herath M. T. K. Karunarathna ◽  
Ranawaka A. P. M. Perera ◽  
Vicky J. Fang ◽  
Hui-ling Yen ◽  
Benjamin John Cowling ◽  
...  

Author(s):  
Diqi Yang ◽  
Minghua Hu ◽  
Hongmei Zhu ◽  
Jianguo Chen ◽  
Dehai Wang ◽  
...  

Abstract The pandemic influenza A (H1N1) virus spread globally and posed one of the most serious global public health challenges. The traditional Chinese medicine is served as a complementary treatment strategy with vaccine immunization. Here, we demonstrated the mixed polysaccharides (MPs) derived from shiitake mushroom, poriacocos, ginger and tyangerine peel prevent the H1N1 virus infections in mice. MPs pretreatment attenuated H1N1 virus-induced weight loss, clinical symptoms and death. The lymphocytes detection results showed the CD3+, CD19+ and CD25+ cell proportions were up-regulated in thymus under MPs pretreatment. Besides, MPs pretreatment reduced the inflammatory cell infiltration and increased the cell proportions of CD19+, CD25+ and CD278+ in lung. However, MPs treatment have no effective therapeutic effect after H1N1 virus challenge. The current study suggested that pretreatment with MPs could attenuate H1N1 virus-induced lung injury and up-regulate humoral and cellular immune responses in non- immunized mice.


2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Babasaheb V Tandale ◽  
Shailesh D Pawar ◽  
Yogesh K Gurav ◽  
Mandeep S Chadha ◽  
Santosh S Koratkar ◽  
...  

2013 ◽  
Vol 03 (07) ◽  
pp. 476-482
Author(s):  
Olea Andrea ◽  
Fasce Rodrigo ◽  
Aguilera Ximena ◽  
Oliva Otavio ◽  
Muñoz Sergio ◽  
...  

2009 ◽  
Vol 14 (21) ◽  
Author(s):  
Collective New influenza A(H1N1) investigation teams*

Since the emergence of a new influenza A(H1N1) virus in North America and its international spread, an active surveillance of cases of infection due to this virus has been set up in France in order to undertake appropriate measures to slow down the spread of the new virus. This report describes the epidemiological and clinical characteristics of the 16 laboratory confirmed cases diagnosed in France as of 20 May 2009.


PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0244596
Author(s):  
Sun Jae Jung ◽  
Sung-Shil Lim ◽  
Jin-Ha Yoon

Aims We explored the association between influenza epidemic and suicide mortality rates in a large population using a time-series regression of 13-year mortality data in South Korea. Methods Weekly suicide mortalities and influenza-like illness (ILI) were analyzed using time series regression. Regression coefficient for suicide mortality based on percentage change of ILI was calculated using a quasi-Poisson regression. Non-linear distributed lag models with quadratic function up to 24 weeks were constructed. Results The association between ILI and suicide mortality increased significantly up to 8 weeks post-influenza diagnosis. A significant positive association between ILI and suicide mortality was observed from 2009, when a novel influenza A(H1N1)pdm09 virus provoked a worldwide pandemic. No meaningful association between these factors was observed before 2009. Conclusion There was a significant positive relationship between ILI and suicide mortality after 2009, when a novel influenza A(H1N1)pdm09 virus provoked a worldwide pandemic.


Sign in / Sign up

Export Citation Format

Share Document